The evolving role of statins in the management of atherosclerosis.
about
Pleiotropic effects of statinsStatins research unfinished saga: desirability versus feasibilityAtherosclerosis: a chronic inflammatory disease mediated by mast cellsProteins and small molecules for cellular regenerative medicineNon-cardiovascular effects associated with statinsPlatelets as predictors of vascular risk: is there a practical index of platelet activity?Current medical management of chronic stable anginaHMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statinsThe effects of the statins lovastatin and cerivastatin on signalling by the prostanoid IP-receptorSoluble epoxide hydrolase in atherosclerosisCamphene, a plant-derived monoterpene, reduces plasma cholesterol and triglycerides in hyperlipidemic rats independently of HMG-CoA reductase activityThiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.Statins and cardiovascular diseases: from cholesterol lowering to pleiotropyAtorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction.Statin therapy is not associated with improved vascular access outcomes.Semisynthesis of novel monacolin J derivatives: hypocholesterolemic and neuroprotective activities.The role of endoplasmic reticulum stress in the progression of atherosclerosis.Rosuvastatin calcium in acute coronary syndromes.Statins in the 21st century: end of the simple story?Statins: mechanism of action and effects.The importance of lipid evaluation and management in the prevention and treatment of acute myocardial infarction.Pharmacologic therapy of lipid disorders in the elderly.New cholesterol guidelines, new treatment challenges.Lipoprotein-associated phospholipase A2: a target directed at the atherosclerotic plaque.Lack of therapeutic interchangeability of HMG-CoA reductase inhibitors.Screening for lung cancer: in pursuit of pre-metastatic disease.Effects of simvastatin on apolipoprotein M in vivo and in vitro.Major peptides from amaranth (Amaranthus cruentus) protein inhibit HMG-CoA reductase activityEpidemiology and management of antiretroviral-associated cardiovascular disease.Noncholesterol-lowering effects of statins.Plaque stabilisation by systemic and local drug administration.The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels.Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosisShould standard medical therapy for angina include a statin?The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatologyFuture prospects of anticytokine therapy in chronic heart failure.Highly upregulated expression of CD36 and MSR1 in circulating monocytes of patients with acute coronary syndromesCholesterol and apolipoprotein E in Alzheimer's disease.The role of statins in preventing stroke.SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals.
P2860
Q24647863-2E230FDF-649F-48A1-8C7D-7F65C74ABF2BQ24811267-6850D27D-0E68-4127-92C0-2E3948AC60BAQ26773173-1FB607A9-A11E-41D8-BF45-7A8C4CFDBD33Q26850495-795B014B-2FC8-4802-BA13-30EE360BB2D8Q27026332-00C46985-C28E-4A06-992D-62202069CDFDQ28165430-55160B53-29A7-471F-A18C-910CBE9F6D7CQ28213164-13CE111F-2733-41ED-967F-9A889685307EQ28344912-6340E374-5065-4521-B984-C8D786FB00F2Q28363003-AB7B56D3-0DD7-4D2E-B397-50507D13A932Q28395004-35D04978-6835-4117-A74F-12DDD24927D0Q28743164-1BA9948F-6349-4040-AACC-8D01C972FBC3Q33585657-8696AD2B-829E-4578-A276-37132E90DE63Q33960556-A8754A53-BCA2-422C-88A4-23CA3663CE62Q34043095-858AC713-12A7-48AC-9041-A793CA2B249BQ34075472-8EE27C36-BDEF-4A5B-8417-61201B5E1A8BQ34127245-4AABDCD2-75A4-4530-BD8E-8DB9EEC42FE5Q34141006-4F88F73E-EB1B-4169-A6F8-CE4FAE2B9EBDQ34338367-4A78EEF6-211F-49C3-A91E-D4A778955989Q34481748-18F011F1-02C6-4536-98B4-07A94A285FEAQ34687736-3EA4D337-85DD-412C-A333-45F6288878B5Q34714717-A114BC47-3FD6-493C-84D6-211B1226C0C0Q34714765-0F987A34-DCC7-4839-B0D7-085E2F9FC5FEQ34748825-EE7EF798-26CB-4999-8658-843EF3719AB5Q34837405-728A5E40-58F7-4C94-9AB0-E6CB7CA9367BQ35009456-AAE4FD9E-B999-43A5-813C-C0E61D002B43Q35037686-146E64D8-264C-4D21-A1B0-F484534DB2E2Q35121822-BA043C1E-EF57-452E-8F6C-A20DCFD22DCDQ35139203-5EAFF6CB-92D8-4CF1-9DF8-87A55CB50D8EQ35338096-30AB4D2B-DE4C-4B99-AD59-1B1E4EBADB0CQ35551180-4081852D-CE4F-4E02-926E-92FDC4EE2DF6Q35583277-D58CDFFE-0933-4358-AFB7-4467E2E630B8Q35684825-C813750F-00DB-4410-8B2E-3EA0A7CE0422Q35923589-46307197-E9D3-4124-9ADF-6F0D8D85944EQ35955693-230A123F-71AA-4CBF-8EB8-1FF280FC9E51Q36059492-B6177F84-1E10-4617-9D71-1D51A7FAF1EBQ36087238-95A94197-ADB7-4094-8D24-22AFCB51E4CBQ36095925-A7ACFC7F-B715-4DFA-8F54-E7DB16E31233Q36103897-4C720385-7317-48B7-B9CE-8C5465856E31Q36110439-4B778755-01C1-4E5D-86B8-F4F229225567Q36184009-6202DB67-7276-457D-9E04-04EC68D64E99
P2860
The evolving role of statins in the management of atherosclerosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The evolving role of statins in the management of atherosclerosis.
@ast
The evolving role of statins in the management of atherosclerosis.
@en
type
label
The evolving role of statins in the management of atherosclerosis.
@ast
The evolving role of statins in the management of atherosclerosis.
@en
prefLabel
The evolving role of statins in the management of atherosclerosis.
@ast
The evolving role of statins in the management of atherosclerosis.
@en
P2093
P1476
The evolving role of statins in the management of atherosclerosis.
@en
P2093
Gotto AM Jr
Vaughan CJ
P356
10.1016/S0735-1097(99)00525-2
P407
P577
2000-01-01T00:00:00Z